ADLIB
Chiome Bioscience Inc.
Trademark Registered: 2017-02-14
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79169309 |
| Registration Number | 5139363 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | M. Scott Alprin |
| Attorney Docket Number | 0021020 |
| Law Office Assigned | N10 |
| Employee Name | MAHONEY, PAULA M |
Timeline
| 2015-04-28 | Application Filed |
| 2016-11-29 | Published for Opposition |
| 2017-02-14 | Status: Live/Registered |
| 2017-02-14 | Trademark Registered |
| 2017-06-23 | Location: POST REGISTRATION |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Chiome Bioscience Inc. |
| Address | 3-12-1 Honmachi Shibuya-ku Tokyo JP 151-0071 |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| B00001 | In the statement, "the entire class 042" should be deleted, and Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; design and development of medical technology; research and development in the field of biotechnology; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; providing temporary use of non-downloadable business software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; rental of computer software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals; cloud computing featuring software for use in research and development of monoclonal antibodies for medical or veterinary purposes and monoclonal antibody-based biopharmaceuticals should be inserted. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2015-07-23 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-07-25 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2015-07-29 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2015-08-08 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2015-08-13 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2015-08-14 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2015-08-14 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-08-14 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2015-09-04 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2016-02-15 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2016-02-15 | 11 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-02-15 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-02-15 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-02-16 | 14 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2016-03-10 | 15 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2016-03-10 | 16 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-03-10 | 17 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2016-09-15 | 18 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2016-09-19 | 19 RCCK S: |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2016-09-23 | 20 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-09-23 | 21 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-09-24 | 22 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-10-13 | 23 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-10-27 | 24 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-11-09 | 25 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2016-11-09 | 26 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2016-11-09 | 27 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2016-11-29 | 28 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-11-29 | 29 NPUB E:E-Mail |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2016-12-16 | 30 EPPA I:Incoming Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2016-12-16 | 31 OPNX P: |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2016-12-28 | 32 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2016-12-28 | 33 OPNS P: |
| ASSIGNED TO PETITION STAFF | 2017-01-31 | 34 APET A:Allowance for Publication |
| APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT | 2017-02-01 | 35 CHPN I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2017-02-14 | 36 R.PR A:Allowance for Publication |
| TEAS SECTION 7 REQUEST RECEIVED | 2017-03-09 | 37 ES7R I:Incoming Correspondence |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2017-05-14 | 38 FICR P: |
| ASSIGNED TO PARALEGAL | 2017-06-06 | 39 PLGL A:Allowance for Publication |
| CERTIFICATE OF CORRECTION ISSUED | 2017-06-23 | 40 COC. O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2017-08-04 | 41 OPNX P: |
| FINAL DISPOSITION PROCESSED | 2017-09-15 | 42 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2017-09-15 | 43 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2017-10-28 | 44 FINO P: |
| PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | 2018-02-23 | 45 INPR P: |
| INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | 2018-03-07 | 46 INNA R:Renewal |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2022-02-14 | 47 REM3 E:E-Mail |
| TEAS SECTION 71 RECEIVED | 2022-11-15 | 48 ES71 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-05-29 | 49 APRE A:Allowance for Publication |
| REGISTERED - PARTIAL SEC 71 ACCEPTED | 2023-06-10 | 50 71.P O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2023-06-10 | 51 NA71 E:E-Mail |
| PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | 2024-02-10 | 52 INPR P: |
| INVALIDATION PROCESSED | 2024-02-26 | 53 INPC P: |
| PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2024-02-26 | 54 INPS P: |
| PARTIAL INVALIDATION PROCESSED BY THE IB | 2024-04-01 | 55 INNP P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 